Xiomara Copeland
FDA investigator
Appears on 3 documents from 2016 to 2019, mostly at sites in Washington. Most often cites batch production and control records (21 CFR 211.188).
- 3
- Documents on file
- 1.7
- Observations per 483
- 2016
- First seen
- 2019
- Most recent
What they cite most
From 5 observations- 21 CFR 211.188Batch production and control records2
- 21 CFR 211.42(c)(10)(iv)Design and construction features2
- 21 CFR 211.192Production record review1
Activity by year
2016: 1, 2019: 2
Where
Washington 2 · Spain 1
Often inspects with
Is Xiomara Copeland coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
3 documents, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2019-07-26 | 483 Jubilant HollisterStier LLCJul 26, 2019 · Spokane, Washington | Spokane, Washington | 1 | |
| 2019-07-26 | 483 Jubilant HollisterStier, LLCJul 26, 2019 · Spokane, Washington | Spokane, Washington | 1 | |
| 2016-04-22 | 483 ROVI Pharma Industrial Services S.A.Apr 22, 2016 · Madrid, Spain | Madrid, Spain | 3 |
About this profile
What does Xiomara Copeland inspect?
Xiomara Copeland appears on 3 documents on file covering 2 sites, mostly in Washington.
What do they cite most often?
21 CFR 211.188 (batch production and control records), followed by 21 CFR 211.42(c)(10)(iv) and 21 CFR 211.192.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Xiomara Copeland is dated Jul 26, 2019.